Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellularly glycine-gated ion channel activity	GLRA1 GLRA2 GLRA3	8.92e-07	6	72	3	GO:0016933
GeneOntologyMolecularFunction	extracellularly glycine-gated chloride channel activity	GLRA1 GLRA2 GLRA3	8.92e-07	6	72	3	GO:0016934
GeneOntologyMolecularFunction	inhibitory extracellular ligand-gated monoatomic ion channel activity	GLRA1 GLRA2 GLRA3	2.48e-06	8	72	3	GO:0005237
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH10 PAFAH1B1 DNAH8 DNAH7	9.38e-06	37	72	4	GO:0045505
GeneOntologyMolecularFunction	glycine-gated chloride ion channel activity	GLRA2 GLRA3	1.28e-05	2	72	2	GO:0022852
GeneOntologyMolecularFunction	glycine binding	GLRA1 GLRA2 GLRA3	1.59e-05	14	72	3	GO:0016594
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH10 DNAH8 DNAH7	3.53e-05	18	72	3	GO:0008569
GeneOntologyMolecularFunction	microtubule motor activity	APPBP2 DNAH10 DNAH8 DNAH7	1.19e-04	70	72	4	GO:0003777
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH10 DNAH8 DNAH7	1.38e-04	28	72	3	GO:0051959
GeneOntologyMolecularFunction	excitatory extracellular ligand-gated monoatomic ion channel activity	GLRA1 GLRA2 GLRA3	5.00e-04	43	72	3	GO:0005231
GeneOntologyMolecularFunction	ligand-gated monoatomic anion channel activity	GLRA1 GLRA2 GLRA3	7.80e-04	50	72	3	GO:0099095
GeneOntologyMolecularFunction	cytoskeletal motor activity	APPBP2 DNAH10 DNAH8 DNAH7	8.75e-04	118	72	4	GO:0003774
GeneOntologyMolecularFunction	ATP hydrolysis activity	DNAH10 ABCC12 SLFN11 DDX60L DNAH8 DNAH7 ABCA10	1.05e-03	441	72	7	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	APPBP2 DNAH10 ABCC12 SLFN11 DDX60L DNAH8 DNAH7 ABCA10	1.62e-03	614	72	8	GO:0140657
GeneOntologyMolecularFunction	transmitter-gated channel activity	GLRA1 GLRA2 GLRA3	1.67e-03	65	72	3	GO:0022835
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity	GLRA1 GLRA2 GLRA3	1.67e-03	65	72	3	GO:0022824
GeneOntologyMolecularFunction	ribosomal small subunit binding	UNG PTCD3	1.68e-03	17	72	2	GO:0043024
GeneOntologyMolecularFunction	amino acid binding	GLRA1 GLRA2 GLRA3	2.33e-03	73	72	3	GO:0016597
GeneOntologyMolecularFunction	growth factor binding	IL1RAPL1 PDGFRB ACVR1 OSMR	2.44e-03	156	72	4	GO:0019838
GeneOntologyMolecularFunction	extracellular ligand-gated monoatomic ion channel activity	GLRA1 GLRA2 GLRA3	2.72e-03	77	72	3	GO:0005230
GeneOntologyMolecularFunction	inorganic anion transmembrane transporter activity	GLRA1 GLRA2 GLRA3 SLC34A2	3.40e-03	171	72	4	GO:0015103
GeneOntologyMolecularFunction	chloride channel activity	GLRA1 GLRA2 GLRA3	3.71e-03	86	72	3	GO:0005254
GeneOntologyCellularComponent	axonemal dynein complex	DNAH10 DRC1 DNAH8 DNAH7	1.73e-06	25	74	4	GO:0005858
GeneOntologyCellularComponent	microtubule associated complex	APPBP2 DNAH10 PAFAH1B1 DRC1 DNAH8 DNAH7	2.29e-05	161	74	6	GO:0005875
GeneOntologyCellularComponent	dynein complex	DNAH10 DRC1 DNAH8 DNAH7	4.00e-05	54	74	4	GO:0030286
GeneOntologyCellularComponent	glycinergic synapse	GLRA1 GLRA2 GLRA3	4.65e-05	20	74	3	GO:0098690
GeneOntologyCellularComponent	inner dynein arm	DNAH10 DNAH7	5.46e-04	10	74	2	GO:0036156
GeneOntologyCellularComponent	postsynaptic membrane	IL1RAPL1 LHFPL4 PTPRO GLRA1 GLRA2 GLRA3 CADPS2	5.74e-04	405	74	7	GO:0045211
GeneOntologyCellularComponent	postsynaptic specialization membrane	IL1RAPL1 PTPRO GLRA1 GLRA2 GLRA3	7.36e-04	201	74	5	GO:0099634
GeneOntologyCellularComponent	axoneme	CFAP54 DNAH10 DRC1 DNAH8 DNAH7	8.40e-04	207	74	5	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	CFAP54 DNAH10 DRC1 DNAH8 DNAH7	8.58e-04	208	74	5	GO:0097014
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	CFAP54 DNAH10 PAFAH1B1 DRC1 DNAH8 DNAH7	9.04e-04	317	74	6	GO:0032838
GeneOntologyCellularComponent	synaptic membrane	IL1RAPL1 LHFPL4 PTPRO GLRA1 GLRA2 CNTNAP2 GLRA3 CADPS2	1.04e-03	583	74	8	GO:0097060
GeneOntologyCellularComponent	chloride channel complex	GLRA1 GLRA2 GLRA3	1.09e-03	57	74	3	GO:0034707
GeneOntologyCellularComponent	perikaryon	SCN1B GLRA1 CNTNAP2 GLRA3 PDE11A	1.17e-03	223	74	5	GO:0043204
GeneOntologyCellularComponent	somatodendritic compartment	IL1RAPL1 CALB1 NF1 SH3GLB1 LHFPL4 PTPRO SCN1B GLRA1 PAFAH1B1 CNTNAP2 GLRA3 PDE11A	1.19e-03	1228	74	12	GO:0036477
GeneOntologyCellularComponent	cytoplasmic region	CFAP54 DNAH10 PAFAH1B1 DRC1 DNAH8 DNAH7	1.73e-03	360	74	6	GO:0099568
GeneOntologyCellularComponent	cell leading edge	KITLG PDGFRB PTPRO PIEZO1 PAFAH1B1 CNTNAP2 DUOX2	1.94e-03	500	74	7	GO:0031252
GeneOntologyCellularComponent	GABA-ergic synapse	CALB1 LHFPL4 PTPRO GLRA2	2.74e-03	164	74	4	GO:0098982
GeneOntologyCellularComponent	actin-based cell projection	CALB1 KITLG AMN1 PAFAH1B1 SLC34A2	3.06e-03	278	74	5	GO:0098858
Domain	Glycine_rcpt_A	GLRA1 GLRA2 GLRA3	2.29e-07	4	73	3	IPR008127
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DNAH8 DNAH7	2.02e-05	14	73	3	IPR024317
Domain	Dynein_HC_stalk	DNAH10 DNAH8 DNAH7	2.02e-05	14	73	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH10 DNAH8 DNAH7	2.02e-05	14	73	3	IPR013602
Domain	DHC_N2	DNAH10 DNAH8 DNAH7	2.02e-05	14	73	3	PF08393
Domain	MT	DNAH10 DNAH8 DNAH7	2.02e-05	14	73	3	PF12777
Domain	AAA_8	DNAH10 DNAH8 DNAH7	2.02e-05	14	73	3	PF12780
Domain	DHC_fam	DNAH10 DNAH8 DNAH7	2.52e-05	15	73	3	IPR026983
Domain	Dynein_heavy_dom	DNAH10 DNAH8 DNAH7	2.52e-05	15	73	3	IPR004273
Domain	Dynein_heavy	DNAH10 DNAH8 DNAH7	2.52e-05	15	73	3	PF03028
Domain	Band_7/stomatin-like_CS	STOML3 STOM	4.51e-05	3	73	2	IPR018080
Domain	BAND_7	STOML3 STOM	4.51e-05	3	73	2	PS01270
Domain	GABAA/Glycine_rcpt	GLRA1 GLRA2 GLRA3	9.59e-05	23	73	3	IPR006028
Domain	TF_AP2	TFAP2A TFAP2C	1.50e-04	5	73	2	IPR004979
Domain	TF_AP2_C	TFAP2A TFAP2C	1.50e-04	5	73	2	IPR013854
Domain	Stomatin_fam	STOML3 STOM	1.50e-04	5	73	2	IPR001972
Domain	TF_AP-2	TFAP2A TFAP2C	1.50e-04	5	73	2	PF03299
Domain	AAA+_ATPase	DNAH10 ABCC12 DNAH8 DNAH7 ABCA10	2.50e-04	144	73	5	IPR003593
Domain	AAA	DNAH10 ABCC12 DNAH8 DNAH7 ABCA10	2.50e-04	144	73	5	SM00382
Domain	DHC_N1	DNAH10 DNAH8	4.16e-04	8	73	2	PF08385
Domain	Dynein_heavy_dom-1	DNAH10 DNAH8	4.16e-04	8	73	2	IPR013594
Domain	Neurotransmitter_ion_chnl_CS	GLRA1 GLRA2 GLRA3	7.23e-04	45	73	3	IPR018000
Domain	Neur_chan_memb	GLRA1 GLRA2 GLRA3	7.71e-04	46	73	3	PF02932
Domain	Band_7	STOML3 STOM	8.10e-04	11	73	2	IPR001107
Domain	Band_7	STOML3 STOM	8.10e-04	11	73	2	PF01145
Domain	PHB	STOML3 STOM	8.10e-04	11	73	2	SM00244
Domain	Neur_chan_LBD	GLRA1 GLRA2 GLRA3	8.21e-04	47	73	3	PF02931
Domain	NEUROTR_ION_CHANNEL	GLRA1 GLRA2 GLRA3	8.21e-04	47	73	3	PS00236
Domain	Neurotrans-gated_channel_TM	GLRA1 GLRA2 GLRA3	8.21e-04	47	73	3	IPR006029
Domain	-	GLRA1 GLRA2 GLRA3	8.21e-04	47	73	3	2.70.170.10
Domain	Neur_channel	GLRA1 GLRA2 GLRA3	8.21e-04	47	73	3	IPR006201
Domain	Neur_chan_lig-bd	GLRA1 GLRA2 GLRA3	8.21e-04	47	73	3	IPR006202
Domain	ATPase_dyneun-rel_AAA	DNAH10 DNAH8	1.33e-03	14	73	2	IPR011704
Domain	AAA_5	DNAH10 DNAH8	1.33e-03	14	73	2	PF07728
Pathway	WP_CILIARY_LANDSCAPE	EHBP1 PAFAH1B1 UQCC1 PSMD12 TFAP2A TFAP2C STOM	2.41e-05	215	57	7	M39734
Pathway	REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS	TFAP2A TFAP2C	1.59e-04	5	57	2	M27767
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH10 DNAH8 DNAH7	1.71e-04	27	57	3	M47755
Pubmed	Glycinergic input of small-field amacrine cells in the retinas of wildtype and glycine receptor deficient mice.	GLRA1 GLRA2 GLRA3	9.25e-09	3	74	3	17920294
Pubmed	Glycinergic input of widefield, displaced amacrine cells of the mouse retina.	GLRA1 GLRA2 GLRA3	3.69e-08	4	74	3	19528249
Pubmed	Expression and mRNA splicing of glycine receptor subunits and gephyrin during neuronal differentiation of P19 cells in vitro, studied by RT-PCR and immunocytochemistry.	GLRA1 GLRA2 GLRA3	3.69e-08	4	74	3	9051263
Pubmed	Activation of glycine receptor phase-shifts the circadian rhythm in neuronal activity in the mouse suprachiasmatic nucleus.	GLRA1 GLRA2 GLRA3	3.69e-08	4	74	3	21486797
Pubmed	Developmental regulation of glycine receptors at efferent synapses of the murine cochlea.	GLRA1 GLRA2 GLRA3	9.22e-08	5	74	3	21850450
Pubmed	Native glycine receptor subtypes and their physiological roles.	GLRA1 GLRA2 GLRA3	9.22e-08	5	74	3	18721822
Pubmed	Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex.	GLRA1 GLRA2 GLRA3	3.22e-07	7	74	3	22988142
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH10 DNAH8 DNAH7	3.31e-06	14	74	3	9373155
Pubmed	Molecular basis for zinc potentiation at strychnine-sensitive glycine receptors.	GLRA1 GLRA2	4.47e-06	2	74	2	16144831
Pubmed	Immunohistochemical expression patterns of AP2alpha and AP2gamma in the developing fetal human breast.	TFAP2A TFAP2C	4.47e-06	2	74	2	18042070
Pubmed	Characterization of the glycinergic input to bipolar cells of the mouse retina.	GLRA1 GLRA3	4.47e-06	2	74	2	16420443
Pubmed	Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.	TFAP2A TFAP2C	4.47e-06	2	74	2	20459791
Pubmed	Regulation of cytoplasmic dynein ATPase by Lis1.	PAFAH1B1 DNAH8	4.47e-06	2	74	2	16481446
Pubmed	Presence of ethanol-sensitive and ethanol-insensitive glycine receptors in the ventral tegmental area and prefrontal cortex in mice.	GLRA1 GLRA2	4.47e-06	2	74	2	34378188
Pubmed	Probing glycine receptor stoichiometry in superficial dorsal horn neurones using the spasmodic mouse.	GLRA1 GLRA3	4.47e-06	2	74	2	21486794
Pubmed	Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.	KLK11 KLK10	4.47e-06	2	74	2	16800740
Pubmed	Phosphorylation of α3 glycine receptors induces a conformational change in the glycine-binding site.	GLRA1 GLRA3	4.47e-06	2	74	2	23834509
Pubmed	Electrophysiological Signature of Homomeric and Heteromeric Glycine Receptor Channels.	GLRA2 GLRA3	4.47e-06	2	74	2	27382060
Pubmed	Structure of the human alpha 2 subunit gene of the glycine receptor--use of vectorette and Alu-exon PCR.	GLRA1 GLRA2	4.47e-06	2	74	2	8973915
Pubmed	Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes.	GLRA1 GLRA2	4.47e-06	2	74	2	2155780
Pubmed	Selective glycine receptor α2 subunit control of crossover inhibition between the on and off retinal pathways.	GLRA2 GLRA3	4.47e-06	2	74	2	22399754
Pubmed	Activator protein-2 impairs the invasion of a human extravillous trophoblast cell line.	TFAP2A TFAP2C	4.47e-06	2	74	2	19443578
Pubmed	AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis.	TFAP2A TFAP2C	4.47e-06	2	74	2	8808408
Pubmed	The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers.	TFAP2A TFAP2C	4.47e-06	2	74	2	30824562
Pubmed	Phylogenetic relationships and chromosomal location of five distinct glycine receptor subunit genes in the teleost Danio rerio.	GLRA1 GLRA2	4.47e-06	2	74	2	11685575
Pubmed	Multiple sites of ethanol action in alpha1 and alpha2 glycine receptors suggested by sensitivity to pressure antagonism.	GLRA1 GLRA2	4.47e-06	2	74	2	15147510
Pubmed	Glycine receptor α3 and α2 subunits mediate tonic and exogenous agonist-induced currents in forebrain.	GLRA2 GLRA3	4.47e-06	2	74	2	28784756
Pubmed	AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.	TFAP2A TFAP2C	4.47e-06	2	74	2	18443366
Pubmed	Stomatin immunoreactivity in ciliated cells of the human airway epithelium.	STOML3 STOM	4.47e-06	2	74	2	12759749
Pubmed	Multifunctional basic motif in the glycine receptor intracellular domain induces subunit-specific sorting.	GLRA1 GLRA3	4.47e-06	2	74	2	19959465
Pubmed	A family of AP-2 proteins down-regulate manganese superoxide dismutase expression.	TFAP2A TFAP2C	4.47e-06	2	74	2	11278550
Pubmed	Functional genomics of AP-2α and AP-2γ in cancers: in silico study.	TFAP2A TFAP2C	4.47e-06	2	74	2	33213447
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	CNTNAP2 CEP152 MED23 CADPS2 FOXJ3	8.85e-06	130	74	5	12421765
Pubmed	Prdm13 regulates subtype specification of retinal amacrine interneurons and modulates visual sensitivity.	CALB1 TFAP2A TFAP2C	1.20e-05	21	74	3	25995483
Pubmed	Sumoylation pathway is required to maintain the basal breast cancer subtype.	TFAP2A TFAP2C	1.34e-05	3	74	2	24835590
Pubmed	Regulation of Hoxa2 in cranial neural crest cells involves members of the AP-2 family.	TFAP2A TFAP2C	1.34e-05	3	74	2	10068641
Pubmed	Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma.	TFAP2A TFAP2C	1.34e-05	3	74	2	32462520
Pubmed	Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis.	NF1 KITLG	1.34e-05	3	74	2	29596064
Pubmed	AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.	TFAP2A TFAP2C	1.34e-05	3	74	2	16636674
Pubmed	Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.	NF1 KITLG	1.34e-05	3	74	2	10620616
Pubmed	Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.	TFAP2A TFAP2C	1.34e-05	3	74	2	15548692
Pubmed	Transcription of cholesterol side-chain cleavage cytochrome P450 in the placenta: activating protein-2 assumes the role of steroidogenic factor-1 by binding to an overlapping promoter element.	TFAP2A TFAP2C	1.34e-05	3	74	2	12145340
Pubmed	A novel alternative spliced variant of the transcription factor AP2alpha is expressed in the murine ocular lens.	TFAP2A TFAP2C	1.34e-05	3	74	2	9758708
Pubmed	Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression.	KLK11 KLK10	1.34e-05	3	74	2	18515984
Pubmed	Androgens act synergistically to enhance estrogen-induced upregulation of human tissue kallikreins 10, 11, and 14 in breast cancer cells via a membrane bound androgen receptor.	KLK11 KLK10	1.34e-05	3	74	2	19383315
Pubmed	Developmental regulation and overexpression of the transcription factor AP-2, a potential regulator of the timing of Schwann cell generation.	TFAP2A TFAP2C	1.34e-05	3	74	2	11553286
Pubmed	Regulation of ASIC channels by a stomatin/STOML3 complex located in a mobile vesicle pool in sensory neurons.	STOML3 STOM	1.34e-05	3	74	2	22773952
Pubmed	AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells.	TFAP2A TFAP2C	1.34e-05	3	74	2	16867219
Pubmed	Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders.	IL1RAPL1 CNTNAP2	1.34e-05	3	74	2	22031302
Pubmed	Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit.	GLRA1 GLRA3	1.34e-05	3	74	2	17154252
Pubmed	Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.	TFAP2A TFAP2C	1.34e-05	3	74	2	12226108
Pubmed	Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value.	TFAP2A TFAP2C	1.34e-05	3	74	2	23036739
Pubmed	Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors.	TFAP2A TFAP2C	1.34e-05	3	74	2	8661133
Pubmed	Early B-cell factors are required for specifying multiple retinal cell types and subtypes from postmitotic precursors.	CALB1 GLRA1 GLRA2	1.81e-05	24	74	3	20826655
Pubmed	Neurobeachin, a protein implicated in membrane protein traffic and autism, is required for the formation and functioning of central synapses.	GLRA1 GLRA2 GLRA3	2.61e-05	27	74	3	19723784
Pubmed	A Grhl2-dependent gene network controls trophoblast branching morphogenesis.	TFAP2A SLC40A1 TFAP2C	2.61e-05	27	74	3	25758223
Pubmed	The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation.	TFAP2A TFAP2C	2.67e-05	4	74	2	19115315
Pubmed	Transcription factor AP-2gamma regulates murine adenosine deaminase gene expression during placental development.	TFAP2A TFAP2C	2.67e-05	4	74	2	9765260
Pubmed	Structural analysis of mouse glycine receptor alpha subunit genes. Identification and chromosomal localization of a novel variant.	GLRA1 GLRA2	2.67e-05	4	74	2	7507926
Pubmed	Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells.	NF1 ZHX2	2.67e-05	4	74	2	16644864
Pubmed	Regulation of AP-2 and apoptosis in developing eye in a vitamin A-deficiency model.	TFAP2A TFAP2C	2.67e-05	4	74	2	12749383
Pubmed	Stomatin-domain proteins.	STOML3 STOM	2.67e-05	4	74	2	21501885
Pubmed	Analysis of melanocyte precursors in Nf1 mutants reveals that MGF/KIT signaling promotes directed cell migration independent of its function in cell survival.	NF1 KITLG	2.67e-05	4	74	2	11401406
Pubmed	The kallikrein family of proteins as urinary biomarkers for the detection of prostate cancer.	KLK11 KLK10	2.67e-05	4	74	2	19560453
Pubmed	Cell death or survival promoted by alternative isoforms of ErbB4.	TFAP2A TFAP2C	2.67e-05	4	74	2	20943952
Pubmed	MMP9 limits apoptosis and stimulates branching morphogenesis during kidney development.	CALB1 KITLG	2.67e-05	4	74	2	19713309
Pubmed	Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice.	CALB1 SLC40A1	2.67e-05	4	74	2	11175792
Pubmed	Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers.	GLRA1 GLRA3	2.67e-05	4	74	2	28883437
Pubmed	Developmentally regulated Ca2+-dependent activator protein for secretion 2 (CAPS2) is involved in BDNF secretion and is associated with autism susceptibility.	CALB1 CADPS2	2.67e-05	4	74	2	19238500
Pubmed	The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.	TFAP2A TFAP2C	2.67e-05	4	74	2	21363924
Pubmed	Pafah1b2 mutations suppress the development of hydrocephalus in compound Pafah1b1; Reln and Pafah1b1; Dab1 mutant mice.	CALB1 PAFAH1B1	2.67e-05	4	74	2	18514414
Pubmed	Stomatin-domain protein interactions with acid-sensing ion channels modulate nociceptor mechanosensitivity.	STOML3 STOM	2.67e-05	4	74	2	23959680
Pubmed	Binding of microtubule-associated protein 1B to LIS1 affects the interaction between dynein and LIS1.	PAFAH1B1 DNAH8	2.67e-05	4	74	2	15762842
Pubmed	Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer.	KLK11 KLK10	2.67e-05	4	74	2	29095848
Pubmed	Expression of Tfap2d, the gene encoding the transcription factor Ap-2 delta, during mouse embryogenesis.	TFAP2A TFAP2C	2.67e-05	4	74	2	12711551
Pubmed	Identification of Arx transcriptional targets in the developing basal forebrain.	CALB1 KITLG CADPS2	2.92e-05	28	74	3	18799476
Pubmed	Developmental dynamics of PAFAH1B subunits during mouse brain development.	CALB1 PAFAH1B1	4.45e-05	5	74	2	22522921
Pubmed	A mechanosensitive peri-arteriolar niche for osteogenesis and lymphopoiesis.	KITLG PIEZO1	4.45e-05	5	74	2	33627868
Pubmed	Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells.	NF1 KITLG	4.45e-05	5	74	2	15039234
Pubmed	Oligodendrocyte precursors guide interneuron migration by unidirectional contact repulsion.	CALB1 PDGFRB	4.45e-05	5	74	2	35587969
Pubmed	Analysis of transcription factor AP-2 expression and function during mouse preimplantation development.	TFAP2A TFAP2C	4.45e-05	5	74	2	16672719
Pubmed	AP-2α and AP-2β regulate dorsal interneuron specification in the spinal cord.	TFAP2A TFAP2C	4.45e-05	5	74	2	27984181
Pubmed	The human reduced folate carrier gene is regulated by the AP2 and sp1 transcription factor families and a functional 61-base pair polymorphism.	TFAP2A TFAP2C	4.45e-05	5	74	2	12228234
Pubmed	Developmental Role of Adenosine Kinase in the Cerebellum.	ADK CALB1	4.45e-05	5	74	2	33863781
Pubmed	Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo.	TFAP2A TFAP2C	4.45e-05	5	74	2	12072434
Pubmed	Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	EHBP1 CNTNAP2 CEP152 ZHX2	6.34e-05	100	74	4	10048485
Pubmed	Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator.	TFAP2A TFAP2C	6.66e-05	6	74	2	11694877
Pubmed	Gene structure and glial expression of the glycine transporter GlyT1 in embryonic and adult rodents.	GLRA1 GLRA2	6.66e-05	6	74	2	7891186
Pubmed	Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2.	TFAP2A TFAP2C	6.66e-05	6	74	2	12586840
Pubmed	Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.	TFAP2A TFAP2C	6.66e-05	6	74	2	15569994
Pubmed	Highly segregated localization of the functionally related vps10p receptors sortilin and SorCS2 during neurodevelopment.	CALB1 KITLG	6.66e-05	6	74	2	29405286
Pubmed	AP-2alpha transcription factor is required for early morphogenesis of the lens vesicle.	TFAP2A TFAP2C	6.66e-05	6	74	2	9918694
Pubmed	Complete loss of Ndel1 results in neuronal migration defects and early embryonic lethality.	CALB1 PAFAH1B1	9.31e-05	7	74	2	16107726
Pubmed	Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the developing olfactory bulb.	TFAP2A TFAP2C	9.31e-05	7	74	2	14572467
Pubmed	3',5'-cyclic nucleotide phosphodiesterase 11A: localization in human tissues.	CCNE1 PDE11A	9.31e-05	7	74	2	15800651
Pubmed	Two regions within the proximal steroidogenic factor 1 promoter drive somatic cell-specific activity in developing gonads of the female mouse.	TFAP2A TFAP2C	9.31e-05	7	74	2	20962249
Pubmed	AP-2ε Expression in Developing Retina: Contributing to the Molecular Diversity of Amacrine Cells.	TFAP2A TFAP2C	9.31e-05	7	74	2	29467543
Pubmed	Integrin receptors are required for cell survival and proliferation during development of the peripheral glial lineage.	TFAP2A TFAP2C	1.24e-04	8	74	2	11319856
Pubmed	Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2.	TFAP2A TFAP2C	1.24e-04	8	74	2	11744733
Pubmed	Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study.	EHBP1 NCOA4	1.24e-04	8	74	2	20717903
Cytoband	1p22	DPYD SH3GLB1	4.78e-04	20	74	2	1p22
Cytoband	Ensembl 112 genes in cytogenetic band chr2q32	ANKAR DNAH7 SLC40A1	7.67e-04	110	74	3	chr2q32
GeneFamily	Glycine receptors	GLRA1 GLRA2 GLRA3	1.54e-07	5	46	3	868
GeneFamily	Dyneins, axonemal	DNAH10 DNAH8 DNAH7	1.02e-05	17	46	3	536
GeneFamily	Kallikreins	KLK11 KLK10	7.43e-04	16	46	2	616
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 CALB1 KITLG SAMD5 CADPS2 TFAP2A	3.85e-07	169	74	6	0332f539a2f7d6dcd081a5d2f567290721f5a329
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 CALB1 KITLG SAMD5 CADPS2 TFAP2A	5.58e-07	180	74	6	788d5fbf688365b5d92d3aa19b9f8e9448f8be5a
ToppCell	LAM-Epithelial-AirwayEpi\|LAM / Condition, Lineage and Cell class	KLK11 KLK10 DRC1 STOML3 DNAH7 TFAP2A	8.13e-07	192	74	6	7404fc65be3b7bd09447725b43fa31819004dfee
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	KLK11 KLK10 SLC34A2 OSMR CADPS2 TFAP2C	8.13e-07	192	74	6	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 DPYD KITLG CNTNAP2 CADPS2 SLC40A1	8.38e-07	193	74	6	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	Biopsy_Other_PF-Epithelial-Differentiating_Ciliated\|Biopsy_Other_PF / Sample group, Lineage and Cell type	KLK11 CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.03e-06	200	74	6	f7b4581d958afbd68f9045af619aaca0ab463439
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	CFAP54 DNAH10 CNTNAP2 DRC1 DNAH7	5.33e-06	151	74	5	8216462e723fec2797387929dde095370947e10a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 CALB1 KITLG CADPS2 TFAP2A	5.68e-06	153	74	5	9b6675ace8a83c8d446b722301d0ec4e6840f3fc
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 CALB1 KITLG CADPS2 TFAP2A	6.44e-06	157	74	5	2c5295043611bac7dfa4aef2146681bce4a33a8f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC192 CALB1 SAMD5 TFAP2A ABCA10	7.06e-06	160	74	5	8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC192 CALB1 SAMD5 TFAP2A ABCA10	7.06e-06	160	74	5	2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ADK TMEM156 DPF3 CNTNAP2 RGS13	9.21e-06	169	74	5	e3ec9468141b6456398dca17dd8eeaabd2462710
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PTPRO DPF3 GLRA1 GLRA2 CNTNAP2	9.47e-06	170	74	5	14aa86a4f526ed6986afcb28c49225522055550c
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PTPRO DPF3 GLRA1 GLRA2 CNTNAP2	1.12e-05	176	74	5	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CALB1 KITLG COX7C CADPS2 TFAP2A	1.12e-05	176	74	5	b942227abf9902ba13fac6c3e9efb0cacc82af94
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALB1 GLRA2 CNTNAP2 SLC40A1 ABCA10	1.15e-05	177	74	5	7af1a19692f7fe8f691178a4e57d62bc379e3d56
ToppCell	Ciliated_cells-A-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	KLK11 KLK10 DNAH10 STOML3 DNAH7	1.22e-05	179	74	5	0e6c22de2e3fb0ff23b3301863cf4011c5c59dff
ToppCell	10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TMEM156 KITLG SCN1B ABCA10 PDE11A	1.22e-05	179	74	5	bc95c3e7edc5fc6fc913b09f087d221df64c6f48
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	ADK KLK10 SLC34A2 OSMR CADPS2	1.28e-05	181	74	5	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	COPD-Epithelial-Basal\|COPD / Disease state, Lineage and Cell class	KLK11 KLK10 OSMR TFAP2A TFAP2C	1.35e-05	183	74	5	0f760e393edc91009bf6c7e02eeac039a1dfb4ed
ToppCell	(4)_B_cells-(4)_B_mantle\|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ADK DPF3 ANKAR CNTNAP2 LAPTM5	1.35e-05	183	74	5	21b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 CALB1 KITLG CADPS2 TFAP2A	1.39e-05	184	74	5	9690d4290e70f9bda889754ffb30b0af1f7cb94b
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADK TMEM156 CNTNAP2 GLRA3 DNAH8	1.43e-05	185	74	5	91c9a3ea1afd97d35bd05648875d29b35fe09128
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.43e-05	185	74	5	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.43e-05	185	74	5	3e39a3cb534dfe2301930f3e2f7e8cefb522c158
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 CALB1 KITLG CADPS2 TFAP2A	1.46e-05	186	74	5	d65fa6d8e8a195ea10cfde1499d096d6acf7a634
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.46e-05	186	74	5	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 CALB1 KITLG CADPS2 TFAP2A	1.46e-05	186	74	5	08632045d499e61dd96ff29a5a9a208afe58dc58
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	KLK11 KLK10 SLC34A2 OSMR CADPS2	1.46e-05	186	74	5	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.46e-05	186	74	5	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADK SAMD5 SLC34A2 OSMR CADPS2	1.46e-05	186	74	5	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	COPD-Epithelial-Club\|World / Disease state, Lineage and Cell class	KLK11 KLK10 SLC34A2 OSMR TFAP2C	1.46e-05	186	74	5	3006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCell	normal-na-Lymphocytic_B-B_naive-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	ADK TMEM156 DPF3 CNTNAP2 LAPTM5	1.54e-05	188	74	5	ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 CALB1 KITLG CADPS2 TFAP2A	1.54e-05	188	74	5	4154f4787483c7e076e87a187733a9f666742c3d
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.58e-05	189	74	5	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 CALB1 KITLG CADPS2 TFAP2A	1.58e-05	189	74	5	8ff3c3232eff9de4b5c9b22ecb82bc509d773f58
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 CALB1 KITLG CADPS2 TFAP2A	1.58e-05	189	74	5	90aae7e806882bebfad78a78e9a16cf56af3ecd4
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	KLK11 KLK10 SLC34A2 OSMR CADPS2	1.58e-05	189	74	5	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFAP54 SLC34A2 DRC1 DNAH7 TFAP2C	1.58e-05	189	74	5	bd91bdfe35294e60d980259b70fe9e60dca2743f
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.62e-05	190	74	5	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)\|343B / Donor, Lineage, Cell class and subclass (all cells)	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.62e-05	190	74	5	169e600e95878000acf5d11f813f9028c7249646
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.62e-05	190	74	5	0cc36117c793d83cf4a1f66f47758a07d6712bd3
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.62e-05	190	74	5	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.62e-05	190	74	5	a90a38fccdbf75a286b4d258fc54920c02b282f7
ToppCell	Ciliated_cells-A\|World / lung cells shred on cell class, cell subclass, sample id	KLK11 KLK10 DNAH10 STOML3 DNAH7	1.62e-05	190	74	5	cd87731aaa7d252424f79cfce9f7931457f17bdf
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 SLC34A2 DRC1 STOML3 DNAH7	1.66e-05	191	74	5	7b5da29109aa28768c67653a1bc0f385c2d2269b
ToppCell	COPD-Epithelial-Club\|COPD / Disease state, Lineage and Cell class	KLK11 KLK10 SLC34A2 OSMR TFAP2C	1.66e-05	191	74	5	c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 SLC34A2 DRC1 STOML3 DNAH7	1.66e-05	191	74	5	fa9f8b50bfc7911c858bc2f9dcd204873d97ac61
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	DNAH10 SLC34A2 DRC1 STOML3 DNAH7	1.66e-05	191	74	5	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAH10 SLC34A2 DRC1 STOML3 DNAH7	1.66e-05	191	74	5	b4e335e798c9617356b8e24412f9270c42dce656
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 SLC34A2 DRC1 STOML3 DNAH7	1.66e-05	191	74	5	c4b223b33c020a064f576711a3d700eb60a2d737
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	KLK11 KLK10 SLC34A2 OSMR CADPS2	1.66e-05	191	74	5	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 EHBP1 DPYD CNTNAP2 SLC40A1	1.66e-05	191	74	5	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3\|TCGA-Ovary / Sample_Type by Project: Shred V9	DPYD PDGFRB SLC34A2 OSMR LAPTM5	1.66e-05	191	74	5	80d30d8eedb4c70b58440646325bc04c5700803e
ToppCell	Control-Epithelial-Ciliated\|Control / Disease group,lineage and cell class （2021.01.30）	DNAH10 SLC34A2 DRC1 STOML3 DNAH7	1.66e-05	191	74	5	cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	DNAH10 SLC34A2 DRC1 STOML3 DNAH7	1.66e-05	191	74	5	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	normal_Lung-Epithelial_cells-Ciliated\|normal_Lung / Location, Cell class and cell subclass	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.70e-05	192	74	5	097a13121820ab4e5cd2365600efccf5ea4ce8c3
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.70e-05	192	74	5	be592e661367affced9ebe80849b466e6adb3a34
ToppCell	Bronchial_Brush\|World / Tissue, Lineage and Cell class of Lung Cells from 10X	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.75e-05	193	74	5	3e693ac4c92576e3f2c9efdd3f1d96d3d336e260
ToppCell	COVID-19_Severe-Platelet\|COVID-19_Severe / disease group, cell group and cell class	TPST2 SCN1B NCOA4 SLC40A1 STOM	1.75e-05	193	74	5	d9c2d2f72f9ea01e089f5d769801bcd7de4da617
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.75e-05	193	74	5	0b62a6ddd7c42efd9f39781971d1438501e1fa8d
ToppCell	LAM-Epithelial-AirwayEpi\|Epithelial / Condition, Lineage and Cell class	KLK11 KLK10 DRC1 STOML3 DNAH7	1.75e-05	193	74	5	f2672d2c495ee12c3b7d132452bde581fa5a7856
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP54 DNAH10 SLC34A2 DRC1 DNAH7	1.75e-05	193	74	5	bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.79e-05	194	74	5	756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADK IL1RAPL1 KITLG PIEZO1 SAMD5	1.79e-05	194	74	5	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 DPYD CNTNAP2 CADPS2 SLC40A1	1.79e-05	194	74	5	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 DPYD PDGFRB CNTNAP2 SLC40A1	1.79e-05	194	74	5	8c37bedb23285735ff3828db3889897fada8c95d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADK IL1RAPL1 KITLG PIEZO1 SAMD5	1.79e-05	194	74	5	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.79e-05	194	74	5	a46238514bca920c3e3713d23c18ba24a09e2a29
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.79e-05	194	74	5	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	CFAP54 DNAH10 SLC34A2 CADPS2 DNAH7	1.84e-05	195	74	5	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.84e-05	195	74	5	649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.84e-05	195	74	5	0e763f36786515698b593e5c93f6a56619c1242d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.84e-05	195	74	5	581b04220587e1d5198b1abd6965965ace7803e7
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 DPYD PDGFRB CNTNAP2 SLC40A1	1.84e-05	195	74	5	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.84e-05	195	74	5	93b1559382a12cfb158aa5fac7386e38b4f87989
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	CFAP54 DNAH10 SLC34A2 CADPS2 DNAH7	1.84e-05	195	74	5	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.84e-05	195	74	5	129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.84e-05	195	74	5	3e70ee987d66d450062d5df3d7c733ccc7344470
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.84e-05	195	74	5	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.84e-05	195	74	5	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	COVID-19-Epithelial-Ciliated_cells\|Epithelial / Condition, Lineage and Cell class	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.88e-05	196	74	5	de7aa31354b019d7321a8ef965d59ce2e8b89276
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.88e-05	196	74	5	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.88e-05	196	74	5	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	CFAP54 DNAH10 SLC34A2 DRC1 DNAH7	1.88e-05	196	74	5	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	COPD-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	ADK KLK11 KLK10 OSMR TFAP2C	1.88e-05	196	74	5	af96fb94886e9395f3e2cd0a293af29229d017fe
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.93e-05	197	74	5	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 DPYD PDGFRB CNTNAP2 SLC40A1	1.93e-05	197	74	5	31a1852911bda38543916585fda34255fd62a134
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.93e-05	197	74	5	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 PDGFRB SAMD5 CNTNAP2 SLC40A1	1.93e-05	197	74	5	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.93e-05	197	74	5	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	COVID-19-Epithelial\|COVID-19 / Condition, Lineage and Cell class	DNAH10 SLC34A2 DRC1 STOML3 DNAH7	1.93e-05	197	74	5	18fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.93e-05	197	74	5	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 DPYD CNTNAP2 CADPS2 SLC40A1	1.93e-05	197	74	5	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFAP54 DNAH10 DRC1 STOML3 DNAH7	1.98e-05	198	74	5	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KLK11 KLK10 SLC34A2 TFAP2A TFAP2C	1.98e-05	198	74	5	5d57acbe0d245f8bd217eeea07af060092898fbd
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 SLC34A2 DRC1 STOML3 DNAH7	2.02e-05	199	74	5	1ee4010d8557564e25e8ee00b914c2dfd9037838
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KLK11 KLK10 SLC34A2 TFAP2A TFAP2C	2.02e-05	199	74	5	a8bfc0b93ad9968cf52a25be86995ffe436bd636
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 SLC34A2 DRC1 STOML3 DNAH7	2.02e-05	199	74	5	1df69c0cb5f759f6a2152521842506a75bb95cae
ToppCell	Mild-Epithelial-Epithelial-\|Mild / Condition, Lineage, Cell class and cell subclass	DNAH10 SLC34A2 DRC1 STOML3 DNAH7	2.02e-05	199	74	5	81115bbd2c10bfdd38376d2075f03a59c31870d2
Computational	AcetylCholine receptors.	GLRA1 GLRA2 GLRA3	2.76e-05	14	47	3	MODULE_328
Computational	Neurotransmitter (GABA) receptor.	GLRA1 GLRA2 GLRA3	3.44e-05	15	47	3	MODULE_215
Computational	Genes in the cancer module 267.	GLRA1 GLRA2 GLRA3	3.44e-05	15	47	3	MODULE_267
Computational	Ion channels.	GLRA1 GLRA2 GLRA3	2.13e-04	27	47	3	MODULE_214
Computational	Ion channels.	SCN1B GLRA1 GLRA2 GLRA3	2.38e-04	70	47	4	MODULE_316
Drug	Atonik	KITLG GLRA1 GLRA2 GLRA3	1.21e-08	9	73	4	CID000069471
Drug	iso-THAZ	GLRA1 GLRA2 GLRA3	1.26e-07	4	73	3	CID003047783
Drug	protostrychnine	GLRA1 GLRA2 GLRA3	1.26e-07	4	73	3	CID005320746
Drug	7-nitroindoline	GLRA1 GLRA2 GLRA3	1.26e-07	4	73	3	CID013566747
Drug	2-(phosphonomethyl)phenylalanine	GLRA1 GLRA2 GLRA3	1.26e-07	4	73	3	CID000383689
Drug	SC-49648	GLRA1 GLRA2 GLRA3	1.26e-07	4	73	3	CID000195696
Drug	akuammiline	GLRA1 GLRA2 GLRA3	1.26e-07	4	73	3	CID005367018
Drug	NSC381080	GLRA1 GLRA2 GLRA3	1.26e-07	4	73	3	CID000165497
Drug	N-methyl-THIP	GLRA1 GLRA2 GLRA3	1.26e-07	4	73	3	CID000134373
Drug	SC-48981	GLRA1 GLRA2 GLRA3	1.26e-07	4	73	3	CID000126573
Drug	SC-50132	GLRA1 GLRA2 GLRA3	1.26e-07	4	73	3	CID000195719
Drug	SR 42641	GLRA1 GLRA2 GLRA3	1.26e-07	4	73	3	CID000129049
Drug	LY233536	KITLG GLRA1 GLRA2 GLRA3	1.72e-07	16	73	4	CID000126239
Drug	azetidine-3-carboxylic acid	GLRA1 GLRA2 GLRA3	3.15e-07	5	73	3	CID000093192
Drug	Lindane	GLRA1 GLRA2 GLRA3	3.15e-07	5	73	3	DB00431
Drug	Cao C	GLRA1 GLRA2 GLRA3	3.15e-07	5	73	3	CID000166617
Drug	oxanilide	GLRA1 GLRA2 GLRA3	3.15e-07	5	73	3	CID000069288
Drug	iso-THAO	GLRA1 GLRA2 GLRA3	3.15e-07	5	73	3	CID000127199
Drug	ALX1393	GLRA1 GLRA2 GLRA3	3.15e-07	5	73	3	CID016078939
Drug	pleiocarpamine	GLRA1 GLRA2 GLRA3	3.15e-07	5	73	3	CID000558637
Drug	mafoprazine	GLRA1 GLRA2 GLRA3	3.15e-07	5	73	3	CID000071241
Drug	gevotroline	GLRA1 GLRA2 GLRA3	3.15e-07	5	73	3	CID000060546
Drug	THAZ	GLRA1 GLRA2 GLRA3	6.28e-07	6	73	3	CID000171289
Drug	mV GABA	GLRA1 GLRA2 GLRA3	6.28e-07	6	73	3	CID000128435
Drug	caged glycine	GLRA1 GLRA2 GLRA3	6.28e-07	6	73	3	CID000192642
Drug	brometone	GLRA1 GLRA2 GLRA3	6.28e-07	6	73	3	CID000006424
Drug	minaxolone	GLRA1 GLRA2 GLRA3	6.28e-07	6	73	3	CID000071960
Drug	thiomuscimol	GLRA1 GLRA2 GLRA3	6.28e-07	6	73	3	CID000005448
Drug	thio-THIP	GLRA1 GLRA2 GLRA3	6.28e-07	6	73	3	CID000656720
Drug	AC1L90PQ	GLRA1 GLRA2 GLRA3	6.28e-07	6	73	3	CID000436036
Drug	alpha-EMTBL	GLRA1 GLRA2 GLRA3	1.10e-06	7	73	3	CID000128423
Drug	CID189778	GLRA1 GLRA2 GLRA3	1.10e-06	7	73	3	CID000189778
Drug	propyl methanethiosulfonate	GLRA1 GLRA2 GLRA3	1.10e-06	7	73	3	CID000529387
Drug	thiocolchicoside	GLRA1 GLRA2 GLRA3	1.10e-06	7	73	3	CID000072067
Drug	L-serinamide	GLRA1 GLRA2 GLRA3	1.10e-06	7	73	3	CID000101138
Drug	Boc-glycine	GLRA1 GLRA2 GLRA3	1.10e-06	7	73	3	CID000078288
Drug	PK 8165	GLRA1 GLRA2 GLRA3	1.10e-06	7	73	3	CID000071219
Drug	WT702	GLRA1 GLRA2 GLRA3	1.75e-06	8	73	3	CID000089643
Drug	isostrychnine	GLRA1 GLRA2 GLRA3	1.75e-06	8	73	3	CID000264626
Drug	Blue Shield	CALB1 GLRA1 GLRA2 GLRA3	2.50e-06	30	73	4	CID000014830
Drug	nortropanol	GLRA1 GLRA2 GLRA3	2.62e-06	9	73	3	CID000068147
Drug	AC1NSJX8	GLRA1 GLRA2 GLRA3	2.62e-06	9	73	3	CID005311059
Drug	NSC129536	GLRA1 GLRA2 GLRA3	2.62e-06	9	73	3	CID000004815
Drug	SR 57227A	GLRA1 GLRA2 GLRA3	2.62e-06	9	73	3	CID000131746
Drug	DCQX	GLRA1 GLRA2 GLRA3	2.62e-06	9	73	3	CID000001845
Drug	NPC 12626	KITLG GLRA1 GLRA2 GLRA3	2.87e-06	31	73	4	CID000108099
Drug	eliprodil	KITLG GLRA1 GLRA2 GLRA3	2.87e-06	31	73	4	CID000060703
Drug	THBA	GLRA1 GLRA2 GLRA3	3.73e-06	10	73	3	CID000130993
Drug	harmaline	CALB1 GLRA1 GLRA2 GLRA3	4.19e-06	34	73	4	CID000022381
Drug	ip 0	GLRA1 GLRA2 GLRA3	5.12e-06	11	73	3	CID000006943
Drug	colchicoside	GLRA1 GLRA2 GLRA3	6.81e-06	12	73	3	CID000092763
Drug	NSC-88789	ADK GLRA1 GLRA2 GLRA3	7.35e-06	39	73	4	CID000002748
Drug	ABPH	GLRA1 GLRA2 GLRA3	1.12e-05	14	73	3	CID000092377
Drug	quinoxaline-2,3-dione	GLRA1 GLRA2 GLRA3	1.12e-05	14	73	3	CID011469229
Drug	ACEA-1011	GLRA1 GLRA2 GLRA3	1.40e-05	15	73	3	CID000127872
Drug	milacemide	GLRA1 GLRA2 GLRA3	1.40e-05	15	73	3	CID000053568
Drug	methanethiosulfonate	SCN1B GLRA1 GLRA2 GLRA3 SLC34A2	2.02e-05	103	73	5	CID004188587
Drug	7-Cl-Thio-Kyna	GLRA1 GLRA2 GLRA3	2.08e-05	17	73	3	CID003035668
Drug	zatosetron	GLRA1 GLRA2 GLRA3	2.08e-05	17	73	3	CID000060763
Drug	beta-alanine	DPYD APPBP2 GLRA1 GLRA2 GLRA3	2.12e-05	104	73	5	CID000000239
Drug	MNQX	GLRA1 GLRA2 GLRA3	2.49e-05	18	73	3	CID000130818
Drug	AC1L1CMQ	GLRA1 GLRA2 GLRA3	2.95e-05	19	73	3	CID000001968
Drug	PNU-120596	GLRA1 GLRA2 GLRA3	2.95e-05	19	73	3	CID000311434
Drug	Brolene	ADK UNG	3.04e-05	3	73	2	CID000011973
Drug	cyanotriphenylborate	GLRA1 GLRA2	3.04e-05	3	73	2	CID000151925
Drug	7-chloro-4-quinolinol	GLRA1 GLRA2	3.04e-05	3	73	2	CID000066593
Drug	1-aminocyclopropane-1-carboxylic acid	ADK PDGFRB GLRA1 GLRA2 GLRA3	3.30e-05	114	73	5	CID000000535
Drug	propanethiol	GLRA1 GLRA2 GLRA3	3.47e-05	20	73	3	CID000007848
Drug	di-Z	GLRA1 GLRA2 GLRA3	3.47e-05	20	73	3	CID000656933
Drug	ethyltrimethylammonium	GLRA1 GLRA2 GLRA3	4.03e-05	21	73	3	CID000033993
Drug	meproadifen	GLRA1 GLRA2 GLRA3	4.03e-05	21	73	3	CID000189752
Drug	R 5135	GLRA1 GLRA2 GLRA3	4.03e-05	21	73	3	CID000119544
Drug	MK-801	CALB1 NF1 KITLG GLRA1 GLRA2 GLRA3 CADPS2	4.58e-05	296	73	7	CID000001207
Drug	Z-Gly	GLRA1 GLRA2 GLRA3	4.66e-05	22	73	3	CID000014349
Drug	Picrotoxin	GLRA2 GLRA3	6.06e-05	4	73	2	DB00466
Drug	seson	ACVR1 STOM	6.06e-05	4	73	2	CID000008701
Drug	1-chloro-1,2,2-trifluorocyclobutane	GLRA1 GLRA2 GLRA3	6.10e-05	24	73	3	CID000079091
Drug	beta-aminoisobutyric acid	DPYD GLRA1 GLRA2	6.10e-05	24	73	3	CID000064956
Drug	SL 75102	GLRA1 GLRA2 GLRA3	6.10e-05	24	73	3	CID005751746
Drug	V-X-A	GLRA1 GLRA2 GLRA3	7.80e-05	26	73	3	CID006369389
Drug	ifenprodil	KITLG GLRA1 GLRA2 GLRA3	8.03e-05	71	73	4	CID000003689
Drug	etomidate	IL1RAPL1 GLRA1 GLRA2 GLRA3	8.03e-05	71	73	4	CID000036339
Drug	pitrazepin	GLRA1 GLRA2 GLRA3	8.75e-05	27	73	3	CID000146222
Drug	L-689,560	GLRA1 GLRA2 GLRA3	8.75e-05	27	73	3	CID000121918
Drug	BN52020	GLRA1 GLRA2 GLRA3	9.78e-05	28	73	3	CID000115221
Drug	AC1NUW3V	GLRA1 GLRA2 GLRA3	1.09e-04	29	73	3	CID005462126
Drug	Glycine	GLRA1 GLRA2 GLRA3	1.21e-04	30	73	3	DB00145
Drug	bilobalide	GLRA1 GLRA2 GLRA3	1.21e-04	30	73	3	CID000073581
Drug	LY235959	GLRA1 GLRA2 GLRA3	1.33e-04	31	73	3	CID000131938
Drug	indole-2-carboxylic acid	GLRA1 GLRA2 GLRA3	1.47e-04	32	73	3	CID000072899
Drug	Asp-Amp	GLRA1 GLRA2	1.51e-04	6	73	2	CID000146213
Drug	MDL 72222	GLRA1 GLRA2 GLRA3	1.76e-04	34	73	3	CID000001683
Drug	dimethoxystrychnine	GLRA1 GLRA2 GLRA3	1.92e-04	35	73	3	CID000009649
Drug	C6H12NO5P	GLRA1 GLRA2 GLRA3	2.09e-04	36	73	3	CID000104962
Drug	uracil analogue	DPYD UNG	2.11e-04	7	73	2	CID000472611
Drug	Fp 3	NF1 TFAP2A	2.11e-04	7	73	2	CID000203335
Drug	Ethanol	GLRA1 GLRA2	2.11e-04	7	73	2	DB00898
Drug	glycine	GLRA1 GLRA2 GLRA3 ABCC12 NCOA4	2.12e-04	169	73	5	CID000000750
Drug	ICS-205,930	GLRA1 GLRA2 GLRA3	2.27e-04	37	73	3	CID000005595
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	EHBP1 NF1 PAFAH1B1 ZHX2 FOXJ3	2.43e-04	174	73	5	7530_DN
Disease	sleep disorder (implicated_via_orthology)	NF1 TFAP2A TFAP2C	2.46e-06	11	74	3	DOID:535 (implicated_via_orthology)
Disease	level of kallikrein-10 in blood serum	KLK11 KLK10	1.86e-05	3	74	2	OBA_2042126
Disease	Autistic Disorder	IL1RAPL1 DPYD NF1 CNTNAP2 CADPS2 SLC40A1	5.06e-05	261	74	6	C0004352
Disease	Autism Spectrum Disorders	IL1RAPL1 DPYD GLRA2 CNTNAP2	6.33e-05	85	74	4	C1510586
Disease	kallikrein-11 measurement	KLK11 KLK10	2.21e-04	9	74	2	EFO_0010573
Disease	ferritin measurement	BAZ2B DUOX2 TFAP2A SLC40A1	2.33e-04	119	74	4	EFO_0004459
Disease	Semantic-Pragmatic Disorder	DPYD CNTNAP2	3.36e-04	11	74	2	C0454655
Disease	Auditory Processing Disorder, Central	DPYD CNTNAP2	3.36e-04	11	74	2	C0751257
Disease	Language Delay	DPYD CNTNAP2	3.36e-04	11	74	2	C0023012
Disease	Language Development Disorders	DPYD CNTNAP2	3.36e-04	11	74	2	C0023014
Disease	Speech Delay	DPYD CNTNAP2	3.36e-04	11	74	2	C0241210
Disease	obsolete_red blood cell distribution width	CCDC192 CCNE1 EHBP1 COG1 FIG4 BAZ2B DPF3 PIEZO1 DUOX2 NCOA4 SLC40A1	5.12e-04	1347	74	11	EFO_0005192
Disease	severe acute respiratory syndrome, COVID-19	IL1RAPL1 GLRA2 SAMD5 DRC1 CADPS2 FBXO47	9.08e-04	447	74	6	EFO_0000694, MONDO_0100096
Disease	Drug toxicity	KITLG SLC34A2 ABCC12	1.25e-03	84	74	3	C0013221
Disease	Adverse reaction to drug	KITLG SLC34A2 ABCC12	1.25e-03	84	74	3	C0041755
Disease	age-related hearing impairment	ADK FIG4 PAFAH1B1 CNTNAP2 COX7C	1.34e-03	324	74	5	EFO_0005782
Disease	QRS duration, response to sulfonylurea	UQCC1 LANCL2	1.52e-03	23	74	2	EFO_0005055, EFO_0007922
Disease	peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease	DPYD CNTNAP2	1.65e-03	24	74	2	EFO_0003948, EFO_0009923, MONDO_0004247
Disease	childhood trauma measurement	IL1RAPL1 SAMD5	1.65e-03	24	74	2	EFO_0007979
Disease	Cerebral Astrocytoma	NF1 ACVR1	1.79e-03	25	74	2	C0750935
Disease	Intracranial Astrocytoma	NF1 ACVR1	1.79e-03	25	74	2	C0750936
Disease	Pilocytic Astrocytoma	NF1 ACVR1	1.79e-03	25	74	2	C0334583
Disease	Astrocytoma	NF1 ACVR1	1.79e-03	25	74	2	C0004114
Disease	Juvenile Pilocytic Astrocytoma	NF1 ACVR1	1.79e-03	25	74	2	C0280783
Disease	Diffuse Astrocytoma	NF1 ACVR1	1.79e-03	25	74	2	C0280785
Disease	Grade I Astrocytoma	NF1 ACVR1	1.79e-03	25	74	2	C1704230
Disease	Subependymal Giant Cell Astrocytoma	NF1 ACVR1	1.79e-03	25	74	2	C0205768
Disease	Mixed oligoastrocytoma	NF1 ACVR1	1.79e-03	25	74	2	C0547065
Disease	Childhood Cerebral Astrocytoma	NF1 ACVR1	1.79e-03	25	74	2	C0338070
Disease	Gemistocytic astrocytoma	NF1 ACVR1	1.94e-03	26	74	2	C0334581
Disease	Protoplasmic astrocytoma	NF1 ACVR1	1.94e-03	26	74	2	C0334580
Disease	Fibrillary Astrocytoma	NF1 ACVR1	1.94e-03	26	74	2	C0334582
Disease	Anaplastic astrocytoma	NF1 ACVR1	2.09e-03	27	74	2	C0334579
Disease	attention deficit hyperactivity disorder (implicated_via_orthology)	FBXO25 NF1	2.25e-03	28	74	2	DOID:1094 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
TWTQMCDIKDVKVVI	UNG	136	P13051
KKYDLNELCTWFMQT	nan	196	A8MVM7
LLWQINEVIHCYKME	CFAP54	646	Q96N23
WMSVQYFEKLKGCIQ	CEP152	1081	O94986
VENKWSLLAKMCLYF	COX7C	31	P15954
KNWMLVEKARVCYIA	ADK	171	P55263
WCFMKNISRYLTDIK	AMN1	16	Q8IY45
MLWKITDNVKYEEDC	TFAP2C	1	Q92754
EKIMYKVTRETHCWE	ABCA10	791	Q8WWZ4
KSIAWEKSIMKVYCQ	BAZ2B	1921	Q9UIF8
TLTSLAKLMKECWYQ	ACVR1	466	Q04771
AILLDWLMEVCEVYK	CCNE1	146	P24864
MCSFLEWRDLKVVYK	AP1S1	46	P61966
MLWKLTDNIKYEDCE	TFAP2A	1	P05549
IMCSYNKNDWTELAK	DPYD	641	Q12882
YKWCIEAMKEITAGL	APPBP2	226	Q92624
MVMCYLKSQWIKETC	OSMR	756	Q99650
SYVKAIDIWMAVCLL	GLRA3	311	O75311
IKMWEVQTGYCVKTF	PAFAH1B1	216	P43034
VWKTLVEMLQCESYK	ANKAR	701	Q7Z5J8
CLMEQIDVTLKWYED	PTCD3	466	Q96EY7
NMTEAVKTYKWQCIE	DPF3	301	Q92784
EKYLKEAMECSDVIW	LANCL2	341	Q9NS86
QYWKQADKIMEEKCI	DDX60L	916	Q5H9U9
GSQMLCKKIYFIWVT	DUOX2	1406	Q9NRD8
CTDWSIDIKKYQVLV	IL1RAPL1	31	Q9NZN1
MVQKFKIDYETLCRW	PDE11A	636	Q9HCR9
AKAWKMLLCRYLNEE	DNAH8	1076	Q96JB1
SWTMVKEMEYICNEL	FAM151B	181	Q6UXP7
CIEILNDMVWKYNIV	MED23	846	Q9ULK4
YMICSSGVEKIIKIW	DCAF5	346	Q96JK2
TKVCKYVDWIQETMK	KLK11	266	Q9UBX7
MLSEDRQLWKKLCQY	FBXO25	261	Q8TCJ0
ILVAVVKMCYEAKEW	PSMD12	66	O00232
TATVYKICAWMQLLA	LHFPL4	121	Q7Z7J7
QRIWDCEEYNMIKIK	DRC1	276	Q96MC2
WMKKKQQFCISDVIY	PTPRO	1196	Q16827
CMQLKVDKEKWLYRT	NCOA4	596	Q13772
LLWLYICTLEAKMQE	ESPL1	681	Q14674
YLKDTLQKWIHMCNE	COG1	346	Q8WTW3
WDMAKYTKSKLCNVL	FIG4	416	Q92562
KKKMTLSEIYQWICD	FOXJ3	96	Q9UPW0
NWYDLKDCSMIKLVD	DNAH7	2071	Q8WXX0
WVIAMDSYDKVAKIV	DNAH7	2796	Q8WXX0
QLKSCEEFMKTWRKY	CALB1	96	P05937
KLFDQWYSSSMKVIC	CADPS2	1201	Q86UW7
VASYQELMVECTKKW	EHBP1	21	Q8NDI1
VSYVKAIDIWMAVCL	GLRA2	311	P23416
LVCEKELYCMDWTVK	FBXO47	361	Q5MNV8
KAKCYNILAAMWTLV	IFITM5	81	A6NNB3
KVYCNMTEDKVWTIV	CNTNAP2	626	Q9UHC6
VWLEMGQCYSKKSVV	CCDC192	16	P0DO97
WENMKFTVVKYCKGT	DNAH10	1406	Q8IVF4
DEIYEIMQKCWEEKF	PDGFRB	931	P09619
IQFWMACETYKKIAS	RGS13	61	O14921
TTCEWKKVFYEKMEV	RTP2	6	Q5QGT7
MCTNIVYEWLKALQL	SAMD5	1	Q5TGI4
ITVLIFKVYMFKCVW	LAPTM5	196	Q13571
SYVKAIDIWMAVCLL	GLRA1	306	P23415
CTKIWTEKIMKQTEV	SH3GLB1	51	Q9Y371
DKYVCSLTTEKWVGM	SLFN11	336	Q7Z7L1
MCVEYVLLWKVYQKT	SLC40A1	216	Q9NP59
MKKTQTWILTCIYLQ	KITLG	1	P21583
LTCIRLIKMYAWEKS	ABCC12	306	Q96J65
WMCIKIIKEYERAII	STOM	51	P27105
WTMKNVTYKENIAKC	SLC34A2	336	O95436
KNITCSMKITWYILV	TMEM156	206	Q8N614
LTKWNKAIEVMYAQC	TPST2	211	O60704
TIWLVAEMIYCYKKI	SCN1B	171	Q07699
SIWMCLKIIKEYERA	STOML3	46	Q8TAV4
WEISSQMLFYICKKL	NF1	571	P21359
WKIKIAALRMYTSCV	UQCC1	111	Q9NVA1
KEVKWTMEVICYGLT	RALGAPB	61	Q86X10
CLLKTGTVKWMEQYQ	ZHX2	681	Q9Y6X8
WTCVIIVCKMLYQLK	PIEZO1	861	Q92508
QICKYMSWINKVIRS	KLK10	261	O43240